Activating Transcription Factor 4 in Erythroid Development and β-Thalassemia: A Powerful Regulator with Therapeutic Potential

Recent research has suggested that activating transcription factor 4 contributes to decreased fetal hemoglobin level through its binding to potent negative regulators of HbF, such as BCL11A and MYB.